GSK Launches $2.5 Billion Buyback, Raises Midterm Sales Outlook
The pharmaceutical company said promising pipeline developments and high demand for drugs in its specialty segment lifted ...
pharmaphorum3d
Five lessons from GSK in social media
The theme of International Women's Day was "inspiring change" and GSK's take on that was to profile inspiring change in the workplace, with content published on the company's website shared via a ...
pharmaphorum5y
GSK finds synergies with global marketing strategy
GSK has shifted towards a global marketing ... While the new CEO has made some high-profile changes to the company’s management team, there have been some changes to the way the company ...
Geneos Wealth Management Inc. Makes New Investment in GSK plc (NYSE:GSK)
Geneos Wealth Management Inc. purchased a new stake in shares of GSK plc (NYSE:GSK – Free Report) during the fourth quarter, ...
Blue Trust Inc. Has $423,000 Position in GSK plc (NYSE:GSK)
Blue Trust Inc. lifted its position in GSK plc (NYSE:GSK – Free Report) by 16.7% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 12,505 shares of the pharmaceutical ...
GlobalData on MSN4mon
GSK reports positive interim data from mRNA influenza vaccine trial
GSK has reported positive interim results ... responses while maintaining a favourable safety profile. Following these ...
GlobalData on MSN8d
GSK and University of Oxford partner for cancer vaccine research
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme.
Yahoo Finance23d
GSK Enters Agreement to Acquire IDRx, Inc.
This breadth of mutational coverage, in addition to high selectivity which could improve tolerability, provides potential for a best-in-class profile. Luke Miels, Chief Commercial Officer ...